FMRP detection assay for the diagnosis of the fragile X syndrome

Citation
R. Willemsen et Ba. Oostra, FMRP detection assay for the diagnosis of the fragile X syndrome, AM J MED G, 97(3), 2000, pp. 183-188
Citations number
48
Categorie Soggetti
Molecular Biology & Genetics
Journal title
AMERICAN JOURNAL OF MEDICAL GENETICS
ISSN journal
01487299 → ACNP
Volume
97
Issue
3
Year of publication
2000
Pages
183 - 188
Database
ISI
SICI code
0148-7299(200023)97:3<183:FDAFTD>2.0.ZU;2-G
Abstract
Fragile X syndrome is almost always caused by the absence or deficit of the FMR1 protein (FMRP). Diagnostic methods include polymerase chain reaction and Southern blotting, which are performed on DNA isolated from peripheral leukocytes. Recently, different immunocytochemical tests have been describe d to identify patients with fragile X syndrome, based on the detection of F MRP in cells by a monoclonal antibody. This review aims to provide an updat e on the different antibody methods for prenatal and postnatal diagnosis of the fragile X syndrome. Am. J. Med. Genet. (Semin. Med. Genet.) 97:183-188 , 2000. (C) 2000 Wiley-Liss, Inc.